source
- Boston Scientific hit by cyberattack causing ‘disruptions’ to parts of its businessThis year has seen a growing number of medtechs hit by cyberattacks, and now Boston Scientific has become the latest victim.Fierce Biotech · 11h ago↗ source
- Spyre’s rheumatoid arthritis plan toppled by subpar TL1A dataPhase 2 data on Spyre Therapeutics’ anti-TL1A antibody SPY072 in rheumatoid arthritis have fallen short of expectations, prompting the biotech to deprioritize monotherapy development in the indicat…Fierce Biotech · 13h ago↗ source
- SK Biopharma pens $795M deal to usher Biohaven’s epilepsy therapy towards hoped-for 2029 launchSK Biopharmaceuticals has strengthened its epilepsy offering by paying $350 million upfront to help speed Biohaven’s Kv7 ion channel activator on its way to market.